When a Glaucoma Diagnosis Hits Home: Beyond Pressure Points and into Patient Lives
Newly diagnosed glaucoma patients carry more than IOP worries. From mental health dips to money matters, quality of care stretches…
Nicox’s NCX 470 Shows Dual IOP-Lowering Promise in Whistler Phase IIIb Trial
New data sheds light on how Nicox’s eye drop may improve outflow and reduce pressure—twice over. Nicox (Sophia Antipolis, France)…
latest posts